Chief Medical Officer of NEUROCRINE BIOSCIENCES INC (U.S.: Nasdaq:NBIX), Roberts Eiry, sells 2,632 shares worth $196,088
According to NEUROCRINE BIOSCIENCES INC's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 12 05:53 PM, company Chief Medical Officer, Roberts Eiry disclosed selling 2,632 shares at a cost of $74.50. At the time of this transaction (Jan 10), this trade was worth $196,088 in total. As of Jan 10, Roberts Eiry now owns 21,279 shares in total worth about $1,596,563.37.
For the last few recent trades made by NEUROCRINE BIOSCIENCES INC (U.S.: Nasdaq:NBIX) Chief Medical Officer, Roberts Eiry, we have the following information:
- SEC Form 4 filing: Feb 08: Sold 2,363 shares at the rate of $116.78 per share. Total worth of this trade was $275,944. Total number of shares owned as of Feb 08 were 17,231
- SEC Form 4 filing: Nov 12: Sold 2,257 shares at the rate of $90.74 per share. Total worth of this trade was $204,810. Total number of shares owned as of Nov 12 were 13,477
- SEC Form 4 filing: Aug 05: Sold 2,257 shares at the rate of $118.84 per share. Total worth of this trade was $268,225. Total number of shares owned as of Aug 05 were 11,446
Posted by
George Daniels
on Thursday January 13 2022, 2:27 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
